The Medicinal Mindfulness Executive Team
Executive Director, Psychedelic Therapist, Principal Organizer DMTx Program
Daniel McQueen (MA) is a professional psychedelic therapist and guide with a Masters in Transpersonal Counseling Psychology from Naropa University. With his wife Alison McQueen (MA, LPC), Daniel is the co-director and manager of Medicinal Mindfulness, a local consciousness community and psychedelic education program in Boulder, Colorado.
Daniel facilitates individual and group psychedelic experiences using psychedelic cannabis blends and transformational breathwork techniques. He is the Principal Organizer of the Medicinal Mindfulness Extended-State DMT Program.
Alison McQueen, MA, LPC, ATR
CLINICAL DIRECTOR, CO-FOUNDER AND PSYCHEDELIC THERAPIST
Alison is a professional psychedelic therapist as well as the Clinical Director and Co-Founder of Medicinal Mindfulness. Trained in MDMA-assisted, cannabis-assisted, and ketamine-assisted psychedelic therapies, Alison also specializes in art therapy, somatic (body-centered) trauma work, harm reduction and psychedelic integration. Her clinical work focuses on mindfulness-based trauma and depth work, conscious parenting and women’s issues.
Alison has a Masters degree in Transpersonal Counseling Psychology (Art Therapy emphasis) from Naropa University, over three years of training in somatic trauma work with the Somatic Training Institute, as well as advanced training and experience as Sub-Investigator and MDMA-Assisted Psychotherapist/Researcher in the Phase 2 MAPS sponsored and FDA-approved study for the treatment of complex post-traumatic stress disorder. Alison has completed Ketamine-Assisted Psychotherapy training with the prestigious Ketamine Training Center and has co-developed Cannabis-Assisted Psychedelic Therapy protocols and trainings with her husband Daniel McQueen of Medicinal Mindfulness.
Bringing together over a decade of experience in the mental health field, clinical research experience in psychedelic therapies, and four years of international experience in therapeutic art education in the Czech Republic, Alison works skillfully and empathically with individuals and groups in cultivating lives of meaning and authenticity.
Alison believes that no one does this work alone, and is inspired by a transparent and collaborative feminist approach to psychotherapy. Your stories, your wisdom, and your vulnerabilities are safe with her. We invite you to reach out so that she may support you on your journey.
Medicinal Mindfulness Advisors
Dr. Carla Clements (PhD, LPC, BCPB)
Principal Investigator DMTx Program & Clinical Advisor
Dr. Carla Clements (PhD, LPC, BCPB) has been a professor at Naropa University in Boulder, CO in the Mindfulness-Based Transpersonal Psychology Department for the last 15 years. She was the chair of the department for a decade, and continues to teach Assessment in Counseling, Group Dynamics, Helping Relationships, and Transpersonal Psychology. In May 2018, she retired to become the Principal Investigator of the DMTx program.
Carla has also maintained a private practice in psychotherapy, specializing in the treatment of PTSD in women, for the past 30 years. During the past three years, Carla was the Independent Rater for the MAPS-sponsored phase 2 study of MDMA-assisted psychotherapy for treatment resistant, chronic PTSD. This experience renewed a lifelong interest in consciousness-expanding compounds which she continues to research today.
Dr. Joseph Cohen, D.O.
Medical Cannabis Consultant
After having practiced as an obstetrician/gynecologist with concomitant training in Functional Medicine at a Yale University hospital, Dr. Cohen subsequently developed an interest in Cannabis Medicine. Having treated thousands of patients with cannabinoids, Dr. Cohen is considered an expert in this new frontier. He believes that the most significant results from the use of cannabis occur when finding, and removing, triggers of disease along with good nutrition and lifestyle choices. Dr. Cohen’s areas of interest include the prevention and treatment of auto-immune disease, dementia and CTE. He is the Medical Director for Journey 2 Life and Holos Health.
Brad serves as Senior Counsel at McAllister Garfield, P.C. and also directs the firms Tribal Cannabis Law Group.
Now entering his third decade of legal practice, Brad regularly advises his clients on business transaction matters including corporate start up, financing, and regulatory and environmental compliance. Brad is also a highly experienced litigator and has handled numerous environmental enforcement cases and American Indian law matters in tribal court, state court and federal trial and appellate courts.
Over the course of this career, Brad has worked extensively throughout Indian Country. Brad regularly advises his clients on developing tribal civil and criminal codes to address cannabis and hemp, establishing tribally owned and operated cannabis businesses and creating joint ventures and other business arrangements. In 2018, Brad scored a decisive federal court victory on behalf of a federally recognized American Indian tribe in Wisconsin upholding the tribe’s ability to cultivate hemp and produce Cannabidiol or CBD.
Brad is licensed to practice law in Colorado and admitted to practice before Federal courts in Colorado and Wyoming as well as the Ninth, Tenth and D.C. Circuit Courts of Appeals.
Prior to joining McAllister Garfield, Brad served as an assistant professor at the University of Denver Sturm School of Law in the Environmental and Natural Resources Law Program and was founder and managing attorney of a prominent environmental/energy law firm.
Brad graduated from the University of Colorado School of Law’s Environmental and American Indian Law program in 1998 and is an enrolled tribal member of the Sault Ste. Marie Band of Chippewa Indians.